Jane Wang

Director Técnico/Científico/I+D en APOLLOMICS, INC. .

61 años

Health Technology

Consumer Services

Perfil

Jane Wang currently works at Apollomics, Inc. (United States), as Chief Scientific Officer and Apollomics, Inc., as Chief Scientific Officer from 2023.
Dr. Wang also formerly worked at Pfizer Inc., as Principal and WuXi AppTec Co., Ltd., as Vice President-Medicinal Chemistry from 2010 to 2022.
Dr. Wang received her doctorate degree from the University of Maryland and undergraduate degree from Fudan University.

Cargos activos de Jane Wang

Empresas	Cargo	Inicio
APOLLOMICS, INC.	Director Técnico/Científico/I+D	30/03/2023
Apollomics, Inc. (United States) Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA.	Director Técnico/Científico/I+D	-

Todos los cargos activos de Jane Wang

Antiguos cargos conocidos de Jane Wang.

Empresas	Cargo	Fin
WUXI APPTEC CO., LTD.	Corporate Officer/Principal	01/07/2022
PFIZER, INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Jane Wang.

Formación de Jane Wang.

Fudan University	Undergraduate Degree
University of Maryland	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jane Wang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	3
APOLLOMICS, INC.	Health Technology
WUXI APPTEC CO., LTD.	Health Technology
PFIZER, INC.	Health Technology

Empresas privadas	1
Apollomics, Inc. (United States) Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA.	Health Technology